Controlled trials of a polyvalent pseudomonas vaccine in burns
- PMID: 91774
- DOI: 10.1016/s0140-6736(79)92559-5
Controlled trials of a polyvalent pseudomonas vaccine in burns
Abstract
A polyvalent pseudomonas vaccine has been tested in controlled clinical trials at two burns units, in Birmingham and New Delhi, in children and adults with burns more than 15% full skin thickness. None of the vaccinated patients in either trial showed blood cultures containing Pseudomonas aeruginosa, and vaccinees showed raised titres of protective antibody and increased phagocytic activity against Ps. aeruginosa. In the New Delhi unit, where death from Ps. aeruginosa infection is common, the mortality in adults was reduced from 40.6% (13/32) in the unvaccinated group to 6.6% (2/30) in the vaccinated group, and in children from 20.8% (5/24) in the unvaccinated group to 4.8% (1/21) in the vaccinated group.
Similar articles
-
Immunization of burned patients against Pseudomonas aeruginosa infection at Safdarjang Hospital, New Delhi.Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S922-30. doi: 10.1093/clinids/5.supplement_5.s922. Rev Infect Dis. 1983. PMID: 6419315 Clinical Trial.
-
[Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].Pol Tyg Lek. 1989 Oct 23-Nov 6;44(43-45):924-7. Pol Tyg Lek. 1989. PMID: 2518666 Clinical Trial. Polish.
-
Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine.J Hyg (Lond). 1979 Jun;82(3):453-62. doi: 10.1017/s0022172400053973. J Hyg (Lond). 1979. PMID: 109501 Free PMC article.
-
Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.Arch Roum Pathol Exp Microbiol. 1982 Apr-Jun;41(2):105-14. Arch Roum Pathol Exp Microbiol. 1982. PMID: 6816188 Review. No abstract available.
-
Vaccines for preventing infection with Pseudomonas aeruginosa in people with cystic fibrosis.Cochrane Database Syst Rev. 2000;(2):CD001399. doi: 10.1002/14651858.CD001399. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD001399. doi: 10.1002/14651858.CD001399.pub2. PMID: 10796780 Updated. Review.
Cited by
-
Protective effect of an outer membrane vaccine against Pseudomonas aeruginosa infection.Infection. 1987;15(5):408-12. doi: 10.1007/BF01647755. Infection. 1987. PMID: 3121520
-
Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.Infect Immun. 1994 Sep;62(9):3608-16. doi: 10.1128/iai.62.9.3608-3616.1994. Infect Immun. 1994. PMID: 7520416 Free PMC article.
-
Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.Infect Immun. 1994 Apr;62(4):1137-43. doi: 10.1128/iai.62.4.1137-1143.1994. Infect Immun. 1994. PMID: 8132318 Free PMC article.
-
Pseudomonas septicaemia.Br Med J. 1980 May 24;280(6226):1240-1. Br Med J. 1980. PMID: 7388486 Free PMC article. No abstract available.
-
Padma Shri Dr J.L. Gupta: A Brilliant Champion of Burns Care in India.Indian J Plast Surg. 2024 May 7;57(2):84-90. doi: 10.1055/s-0044-1786816. eCollection 2024 Apr. Indian J Plast Surg. 2024. PMID: 38774739 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources